137 related articles for article (PubMed ID: 15581963)
1. The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women.
Sull JW; Jee SH; Yi S; Lee JE; Park JS; Kim S; Ohrr H
Gynecol Oncol; 2004 Dec; 95(3):557-63. PubMed ID: 15581963
[TBL] [Abstract][Full Text] [Related]
2. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women.
Silva NNT; Sabino AP; Tafuri A; Lima AA
BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928
[TBL] [Abstract][Full Text] [Related]
4. Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12.
Tong SY; Kim MK; Lee JK; Lee JM; Choi SW; Friso S; Song ES; Lee KB; Lee JP
Cancer Causes Control; 2011 Jan; 22(1):63-72. PubMed ID: 21052817
[TBL] [Abstract][Full Text] [Related]
5. The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women.
Tong SY; Lee JM; Song ES; Lee KB; Kim MK; Yun YM; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
Cancer Causes Control; 2010 Jan; 21(1):23-30. PubMed ID: 19760026
[TBL] [Abstract][Full Text] [Related]
6. The effect of codon 98 of the FHIT gene on cervical cancer in Korean women.
Jee SH; Um SJ; Lee JE; Kim S; Kim JH; Lee SJ; Namkoong SE; Park JS
Int J Gynecol Cancer; 2003; 13(6):843-8. PubMed ID: 14675322
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
Wu CY; Yang M; Lin M; Li LP; Wen XZ
Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325
[TBL] [Abstract][Full Text] [Related]
8. Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily.
Agodi A; Barchitta M; Cipresso R; Marzagalli R; La Rosa N; Caruso M; Castiglione MG; Travali S
Int J Gynecol Cancer; 2010 Jan; 20(1):141-6. PubMed ID: 20130515
[TBL] [Abstract][Full Text] [Related]
9. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis.
Zhu J; Wu L; Kohlmeier M; Ye F; Cai W
Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.
Piyathilake CJ; Macaluso M; Johanning GL; Whiteside M; Heimburger DC; Giuliano A
Anticancer Res; 2000; 20(3A):1751-7. PubMed ID: 10928104
[TBL] [Abstract][Full Text] [Related]
11. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
[TBL] [Abstract][Full Text] [Related]
12. The association between MTHFR polymorphism and cervical cancer.
Gong JM; Shen Y; Shan WW; He YX
Sci Rep; 2018 May; 8(1):7244. PubMed ID: 29740106
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer.
Botezatu A; Socolov D; Iancu IV; Huica I; Plesa A; Ungureanu C; Anton G
J Cell Mol Med; 2013 Apr; 17(4):543-9. PubMed ID: 23444906
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis.
Luo YL; Ye P; Zhang QH; Hu TT; Luo MH; Li MQ; Chen Q
PLoS One; 2012; 7(9):e46272. PubMed ID: 23029458
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia.
Lambropoulos AF; Agorastos T; Foka ZJ; Chrisafi S; Constantinidis TC; Bontis J; Kotsis A
Cancer Lett; 2003 Mar; 191(2):187-91. PubMed ID: 12618332
[TBL] [Abstract][Full Text] [Related]
16. Allelic variations in 5, 10-methylenetetrahydrofolate reductase gene and susceptibility to cervical cancer in Indian women.
Nandan NK; Wajid S; Biswas S; Juneja SS; Rizvi M; Prakash R; Naqvi SH
Drug Metab Lett; 2008 Jan; 2(1):18-22. PubMed ID: 19356065
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis.
Long S; Yang X; Liu X; Yang P
PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018
[TBL] [Abstract][Full Text] [Related]
18. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
19. The effect of methylenetetrahydrofolate reductase polymorphisms on susceptibility to human papilloma virus infection and cervical cancer.
Hajiesmaeil M; Tafvizi F; Sarmadi S
Infect Genet Evol; 2016 Dec; 46():1-6. PubMed ID: 27771518
[TBL] [Abstract][Full Text] [Related]
20. A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era.
Badiga S; Johanning GL; Macaluso M; Azuero A; Chambers MM; Siddiqui NR; Piyathilake CJ
PLoS One; 2014; 9(10):e110093. PubMed ID: 25302494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
